Background -A case of primary thyroid T cell lymphoma leading to lethal tracheal perforation during chemotherapy is described.
Case report A 74 year old man with emphysema presented with a six month history of sore throat, cough, hoarseness, and mild dysphagia. Additional systemic complaints included general malaise, fever, night sweats, and a 9 kg weight loss.
Physical examination revealed mild inspiratory stridor, a 5 cm x 6 cm mass in the left lobe of the thyroid gland, an 8 cm x 6 cm subcutaneous right axillary mass, and two smaller subcutaneous truncal lesions. The patient had no palpable lymphadenopathy. Indirect laryngoscopy showed a mass involving the left pyriform sinus and oedema of the left aryepiglottic fold.
An intravenous contrast enhanced computed tomographic (CT) scan of the neck and chest showed a large heterogeneous thyroid mass with marked irrregularity of the adjacent anterior and lateral tracheal walls due to tumour invasion (fig 1) . The tumour and associated tracheal wall irregularity extended caudally to 4 cm above the tracheal carina. No mediastinal lymphadenopathy or pulmonary metastases were identified. A CT scan ofthe abdomen and pelvis and bone marrow analysis were normal.
Intravenous dexamethasone was administered to alleviate airway compromise following fine needle aspiration of the thyroid mass, which showed that the tumour was an intermediate grade T cell lymphoma. The patient's stridor improved markedly in response to steroid therapy while staging investigations were completed. The lymphoma was staged as IVB, with two sites of bulky disease in the thyroid and skin.
Chemotherapy consisting of cisplatin, doxorubicin, and methylprednisolone was initiated. On the second day of this regimen the patient developed subcutaneous emphysema and dyspnoea following a paroxysm of coughing. Increasing respiratory distress necessitated endotracheal intubation with only transient improvement of symptoms. The patient's condition again deteriorated, with a dramatic worsening of subcutaneous emphysema in the neck and chest (fig 2) and difficulty with mechanical ventilation. He was transiently resuscitated from electromechanical dissociation by repositioning of the endotracheal tube.
Bronchoscopic examination revealed necrotic tumour and blood almost completely occluding the upper airway. In an effort to re-establish a patent airway a bedside tracheostomy was performed for a presumed high tracheal perforation. The cartilaginous portion of the trachea was completely necrotic from the cricoid cartilage to 4 cm above the carina. The remaining distal trachea, which had retracted into the mediastinum, was delivered into the neck incision by an Allis clamp and intubated with a long tracheostomy tube. After a short period ofventilatory and haemodynamic stability, all remaining cartilaginous rings dissolved. The patient died of extensive necrosis of the entire cartilaginous trachea. mon: hoarseness (9-67%), dysphagia (9-60%), and dyspnoea or stridor (9-35%).5 Although the optimal treatment for thyroid lymphoma is uncertain, patients with stage IIE or more advanced disease should probably receive chemotherapy in addition to local treatment (surgery and/or radiotherapy).6
Perforation of the gastrointestinal tract at the site of disease in patients with gastrointestinal lymphoma who are receiving chemotherapy has been well described;' a similar perforation has been reported in a patient with thyroid lymphoma metastatic to the small bowel.7
Lethal tracheal perforation during chemotherapy has not previously been described in a patient with primary thyroid lymphoma. Most series of patients with thyroid lymphoma fail to mention whether the tumour invaded the trachea or larynx.4 In one report two patients demonstrated obstructive symptoms and biopsy proven tracheal invasion by thyroid lymphoma; both patients received chemotherapy with resolution ofobstruction and without tracheal perforation, and both were alive one and two years later without evidence of disease.5
Computed tomographic scanning is the recommended method of assessment of extrathyroid extension of lymphoma.' Early awareness of tracheal involvement by lymphoma should alert the clinician to the remote possibility of tracheal dissolution during treatment of this extremely difficult clinical problem.
Lymphomas are the seventh most common malignancy and the incidence of non-Hodgkin's lymphoma is increasing. Correct diagnosis is important as they are treatable and, in some cases, curable. Lymphomas can involve any organ system and, as thoracic involvement is common, they often present to respiratory physicians. The diagnosis is not always straightforward and treatment is complex. 
